At some point your child may need stem cell treatment – whether that’s for a blood cancer, genetic disorder, brain injury or something as common as a sports injury or skin condition.

Smart Cells has now released more samples for clinical use than any other private storage company in the UK with a 100 per cent success rate. These have been used by patients all around the world to treat a range of conditions including Cerebral Palsy, Thalassemia, Leukaemia, and HSV Encephalitis.

This significant milestone for the industry highlights the advances being made in stem cell research, a service many parents-to-be are not yet aware of. Smart Cells is working to change that – and help more parents protect their children’s wellbeing and future.

Order Now

Our transplant stories

Smart Cells clients tell us how storing their baby’s stem cells changed their lives.

Mohammad Ahmad

Cord blood stem cell samples were collected from their newborn and used to help treat their son who was suffering from Thalassemia Major.

Kyle Carla Poppleton

Their daughter Paige was diagnosed with Cerebral Palsy. We released and shipped their cord blood unit to Dukes University in North Carolina, USA for use in a successful transplant.

Asia’s Story

Asia was diagnosed with mild spastic tetraparesis due to a lack of oxygen at birth. We released cord blood that was used in a successful cord blood transfusion to help with her recovery.

Stem cell transplantation has
become an established procedure

cord blood
collections have
been undertaken
globally

hematopoietic stem
cell transplants take
place every year

0/0

of these transplants
are in Europe

Smart Cells have released 21 samples to six countries.

Stem cells hold the key to more than 80 life-changing treatments, with clinical trials underway on many more. Replacing damaged cells and tissue, they can even save a child’s life.

100% success rate

For samples released for transplant.

3 months – 12 yrs old

Stored cord blood samples have been successfully released for use in transplant for children aged as little as 3 months to 12 years old.

48% self | 52% siblings

Smart Cells have successfully released stored cord blood samples that have been used for treatment with the child it was collected from and also siblings.

FamiCord Group releases

6823

patients

Leukaemia

2156

Multiple myeloma

532

Cerebral Palsy

381

Autism

245

Spinal cord injury

Type 1 Diabetes

Thalassemia

Brain Damage

Medical condition	Sample release date	Recipient relationship	Recipient age	Unit volume	Medical centre	Country
Leukaemia	Nov 2006	Allogeneic (Sibling)	Restricted	Restricted	Stem Cells and Immunology Department, Birmingham	UK
Leukaemia	Jan 2014	Allogeneic (Sibling)	4 Years	71ml	Medizinische Hochschule, Hanover	Germany
Thalassemia	Nov 2005	Allogeneic (Sibling)	4 Years	144ml	Mount Vernon Hospital	Singapore
Thalassemia	Feb 2007	Allogeneic (Sibling)	7 Years	76ml	Kinderlink der Tu Munchen	Germany
Thalassemia	Oct 2013	Allogeneic (Sibling)	5 Years	58ml	Catherine Lewis Centre, Hammersmith	UK
Thalassemia	Nov 2015	Allogeneic (Sibling)	12 Years	87ml	Children’s Hospital of Pittsburgh of UPMC	USA
Cerebral Palsy	Aug 2009	Autologous (Self)	3 Years	51ml	Duke University, North Carolina	USA
Cerebral Palsy	Jan 2010	Autologous (Self)	3 Years	81ml	Duke University, North Carolina	USA
Cerebral Palsy	May 2014	Autologous (Self)	1 year	68ml	Duke University, North Carolina	USA
Cerebral Palsy	Mar 2016	Allogeneic (Sibling)	6 Years	101ml	Duke University, North Carolina	USA
Cerebral Palsy	Jun 2017	Autologous (Self)	7 Years	82ml	Duke University, North Carolina	USA
Cerebral Palsy	Jun 2017	Autologous (Self)	3.5 Years	132ml	Duke University, North Carolina	USA
Cerebral Palsy	Jun 2019	Allogeneic (Sibling)	3 Years	104ml	Duke University, North Carolina	USA
Autism	Mar 2018	Autologous (Self)	5.4 Years	73ml	Duke University, North Carolina	USA
Acute Lymphocytic Leukaemia	Apr 2011	Allogeneic (Sibling)	8 Years	130ml	Royal Marsden Hospital	UK
Lymphoblastic Leukaemia (^1)	Apr 2017	N/A (Identical twin girls)	Restricted	125ml	Bambin Gesu Childrens’ Hospital, Rome	Italy
HSV Encephalitis & NMDA Receptor Antibody Virus	Jun 2014	Autologous (Self)	2 Years	57ml	Duke University, North Carolina	USA
Sickle Cell Disease	May 2015	Allogeneic (Sibling)	2 .5 Years	57ml	BLK Hospital, New Delhi	India
Hypoxic Ischemic Encephalopathy (HIE)	Aug 2014	Autologous (Self)	3 Months	39ml	Duke University, North Carolina	USA
Hypoxic Ischemic Encephalopathy (HIE)	Feb 2015	Autologous (Self)	6 Months	53ml	Duke University, North Carolina	USA
Severe Combined Immune Deficiency	Mar 2015	Autologous (Self)	3 Months	74ml	Duke University, North Carolina	USA

slide 1

The leukaemias are a group of cancers of the blood and bone marrow. Broadly speaking, these diseases can be classified as acute or chronic. Some leukaemias, particularly in the acute category, can progresses rapidly and aggressively and thus requires prompt treatment, whereas others are slower to progress.

some text

slide 2

some text

slide 3

some text

slide 4

some text